These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6441248)

  • 21. Is there a need to reclassify adult rheumatoid arthritis?
    Buchanan WW; Singal DP
    Br J Rheumatol; 1990 Oct; 29(5):377-81. PubMed ID: 2099757
    [No Abstract]   [Full Text] [Related]  

  • 22. HLA DR antigens and gold toxicity.
    Gran JT; Husby G; Thorsby E
    Ann Rheum Dis; 1983 Feb; 42(1):63-6. PubMed ID: 6402993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis.
    Hakala M; van Assendelft AH; Ilonen J; Jalava S; Tiilikainen A
    Ann Rheum Dis; 1986 Mar; 45(3):177-82. PubMed ID: 3456743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA antigens and drug toxicity in rheumatoid arthritis.
    Ford PM
    J Rheumatol; 1984 Jun; 11(3):259-61. PubMed ID: 6610749
    [No Abstract]   [Full Text] [Related]  

  • 26. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
    Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
    Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.
    Tishler M; Caspi D; Gazit E; Yaron M
    Ann Rheum Dis; 1988 Mar; 47(3):215-7. PubMed ID: 2965554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.
    Gladman DD; Anhorn KA
    J Rheumatol; 1986 Apr; 13(2):274-6. PubMed ID: 3459890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis.
    van Riel PL; Reekers P; van de Putte LB; Gribnau FW
    Tissue Antigens; 1983 Sep; 22(3):194-9. PubMed ID: 6415865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole.
    Husain Z; Runge LA
    J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of HLA phenotypes on the response to parenteral gold in rheumatoid arthritis.
    Speerstra F; van Riel PL; Reekers P; van de Putte LB; Vandenbroucke JP
    Tissue Antigens; 1986 Jul; 28(1):1-7. PubMed ID: 3092399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance costs of gold and penicillamine.
    Somerville W; Caughey DE; Grigor RR
    N Z Med J; 1979 Mar; 89(631):186. PubMed ID: 287942
    [No Abstract]   [Full Text] [Related]  

  • 35. Osteoporosis in the rheumatoid hand--the effects of treatment with D-penicillamine and oral gold salts.
    Schorn D
    S Afr Med J; 1983 Jan; 63(4):121-3. PubMed ID: 6401365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse reactions to D-penicillamine after gold toxicity.
    Dodd MJ; Griffiths ID; Thompson M
    Br Med J; 1980 Jun; 280(6230):1498-500. PubMed ID: 6770953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DR antigens and gold toxicity in white rheumatoid arthritis patients.
    Barger BO; Acton RT; Koopman WJ; Alarcón GS
    Arthritis Rheum; 1984 Jun; 27(6):601-5. PubMed ID: 6587852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement C4 null alleles as a marker of gold or D-penicillamine toxicity in the treatment of rheumatoid arthritis.
    Clarkson RW; Sanders PA; Grennan DM
    Br J Rheumatol; 1992 Jan; 31(1):53-4. PubMed ID: 1730108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of continuing penicillamine and gold treatment on the course of penicillamine and gold nephropathy.
    Hall CL; Tighe R
    Br J Rheumatol; 1989 Feb; 28(1):53-7. PubMed ID: 2917229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.